Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

Individuals with psoriasis have a 20% higher risk of developing OSA, even after adjusting for common risk factors. The study utilized a large dataset, enhancing the generalizability of its findings ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

Tirzepatide (Zepbound and Mounjaro), which is approved for chronic weight management and treatment of type 2 diabetes, has significant benefits for patients with moderate-to-severe obstructive sleep ...

A high risk of obstructive sleep apnea (OSA) was associated with higher odds of a composite of depression and mental health ...

Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen’s presence in the growing ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Preexisting ...

Joseph Curley, MD, is employed by Upstate Anesthesia Services, P.C., and is chief of anesthesiology at St. Mary’s Hospital in Troy, N.Y. Upstate Anesthesia Services is managed by Somnia, Inc. Q: Why ...